130 related articles for article (PubMed ID: 13191601)
1. [30 Cases of hemoblastosis and 6 cases of neoplasms of various types treated with triethylenemelamine].
STORTI E; MANZINI E
G Ital Chemioter; 1954; 1(1):116-9. PubMed ID: 13191601
[No Abstract] [Full Text] [Related]
2. [Clinical contribution to the treatment of various types of hemoblastosis with triethylene melamine].
CATTANEO O
G Ital Chemioter; 1954; 1(3-4):557-8. PubMed ID: 14391668
[No Abstract] [Full Text] [Related]
3. [Triethylenemelanine in the treatment of lymphogranulomatoses and hemoblastoses].
WINKLER A; CERNY V
Cesk Onkol; 1954; 1(1):30-8. PubMed ID: 14390616
[No Abstract] [Full Text] [Related]
4. [The therapeutic effect of triethylene melamine in hemoblastosis].
SCHULZE E; FRANKE R; THIELE FH
Arztl Wochensch; 1953 Jul; 8(29):690-4. PubMed ID: 13080055
[No Abstract] [Full Text] [Related]
5. [Therapy of malignant diseases with triethylene melamine].
ROMEO ORBEGOZO JM
Rev Clin Esp; 1953 Sep; 50(5):382-6. PubMed ID: 13134813
[No Abstract] [Full Text] [Related]
6. Urethane plus triethylene melamine therapy in human cancer cases.
BLACK MM; SPEER FD
N Y State J Med; 1954 May; 54(10):1477-80. PubMed ID: 13154643
[No Abstract] [Full Text] [Related]
7. [Treatment of hemoblastosis with triethylene melamine].
LINKE A; LASCH HG
Dtsch Med Wochenschr; 1953 Jun; 78(25):911-6. PubMed ID: 13068032
[No Abstract] [Full Text] [Related]
8. [Use of triethylene melamine in the treatment of neoplasms].
DI PIETRO S
Minerva Med; 1953 Mar; 44(19):585-92. PubMed ID: 13071885
[No Abstract] [Full Text] [Related]
9. [Triethylene melamine therapy of malignant granulomatosis and certain other malignant diseases].
HANSEN PB; BICHEL J
Nord Med; 1952 Jan; 47(2):58-61. PubMed ID: 14910945
[No Abstract] [Full Text] [Related]
10. [Triethylene melamine: new chemotherapeutic agent for tumors].
ROETTEGLIA E
Minerva Farm; 1953 May; 2(5):177. PubMed ID: 13086708
[No Abstract] [Full Text] [Related]
11. [Triethylene melamine, a new agent in the treatment of cancer].
ROCCHIETTA S
Boll Chim Farm; 1952 Oct; 91(10):407-9. PubMed ID: 13032250
[No Abstract] [Full Text] [Related]
12. [Studies on the treatment of malignant disease. V].
KOYAMA Y; KONO M; TAKEMASA Y; HUKUDA R; AMAKI I
Gan; 1956 Dec; 47(3-4):313-5. PubMed ID: 13415017
[No Abstract] [Full Text] [Related]
13. Triethylene melamine in clinical cancer chemotherapy.
GELLHORN A; KLIGERMAN MM; JAFFE I
Am J Med; 1952 Oct; 13(4):428-31. PubMed ID: 12985600
[No Abstract] [Full Text] [Related]
14. Oral triethylene melamine therapy in human neoplastic disease.
BLACKBURN EK; KING GM
J Fac Radiol; 1954 Oct; 6(2):96-103. PubMed ID: 24543599
[No Abstract] [Full Text] [Related]
15. Clinical observations on the use of triethylenemelamine.
BAYRD ED; STICKNEY JM; HALL BE; WATKINS CH
Cancer; 1952 Mar; 5(2):336-43. PubMed ID: 14905420
[No Abstract] [Full Text] [Related]
16. The oral use of triethylene melamine; a compound with nitrogen mustard-like activity.
KARNOFSKY DA; BURCHENAL JH; BERNSTEIN JL; SOUTHAM CM
Acta Unio Int Contra Cancrum; 1953; 9(1):97-100. PubMed ID: 13057680
[No Abstract] [Full Text] [Related]
17. Experience with triethylene melamine (TEM) and triethylene thiophosphoramide (thioTEPA) in recurrent or metastatic solid tumors.
SCHELL RF; HALL BE
Surg Gynecol Obstet; 1958 Apr; 106(4):459-65. PubMed ID: 13529522
[No Abstract] [Full Text] [Related]
18. [Treatment of malignant tumors, especially with nitromin and TEM].
KOYAMA Y; KUMATORI T; TAKEMASA Y
Gan; 1953 Sep; 44(2-3):374-6. PubMed ID: 13128202
[No Abstract] [Full Text] [Related]
19. Triethylene melamine in human malignant disease; results with oral administration of enteric-coated tablets.
PATERSON E; KUNKLER PB; WALPOLE AL
Br Med J; 1953 Jan; 1(4801):59-64. PubMed ID: 12997844
[No Abstract] [Full Text] [Related]
20. [Triethylene-melamine and its combinations in therapy of hemolymphoblastosis].
MARMONT A; FUSCO F
Arch Maragliano Patol Clin; 1954; 9(5):1179-250. PubMed ID: 13229519
[No Abstract] [Full Text] [Related]
[Next] [New Search]
